• FirefoxInstall the new Firefox »
  •  Dow Down0.23% Nasdaq Down0.27%

    Synageva BioPharma Corp. (GEVA)

    -NMS
    92.67 Down 0.62(0.66%) Mar 26, 4:00PM EDT
    |After Hours : 92.65 Down 0.02 (0.02%) Mar 26, 7:54PM EDT
    Add to Portfolio
    Cash FlowGet Cash Flow for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Sep 30, 2014Jun 30, 2014Mar 31, 2014
    Net Income (57,665) (48,319) (50,240) (36,424)
    Operating Activities, Cash Flows Provided By or Used In
    Depreciation2,743  2,336  2,696  2,094  
    Adjustments To Net Income10,159  6,849  4,245  3,181  
    Changes In Accounts Receivables376  879  (795)(73)
    Changes In Liabilities3,579  (608)8,518  (263)
    Changes In Inventories -   -   -   -  
    Changes In Other Operating Activities406  (1,269)23  (2,552)
    Total Cash Flow From Operating Activities (40,402) (40,132) (35,553) (34,037)
    Investing Activities, Cash Flows Provided By or Used In
    Capital Expenditures(2,730)(5,159)(5,632)(3,245)
    Investments44,350  51,176  (46,235)(76,927)
    Other Cash flows from Investing Activities -  (536) -  320  
    Total Cash Flows From Investing Activities 41,620   45,481   (51,867) (79,852)
    Financing Activities, Cash Flows Provided By or Used In
    Dividends Paid -   -   -   -  
    Sale Purchase of Stock5,010  884  5,555  204,088  
    Net Borrowings(78)(95) -   -  
    Other Cash Flows from Financing Activities -   -   -   -  
    Total Cash Flows From Financing Activities 4,932   789   5,555   204,088  
    Effect Of Exchange Rate Changes(34)(54)(13)(5)
    Change In Cash and Cash Equivalents 6,116   6,084   (81,878) 90,194  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.